Delivery Order SPE2DB22D1017-SPE2DB25FYSHR
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $106,966.00 to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100-count units). This firm fixed-price, competitively awarded contract, with no set-aside designation, was finalized on September 22, 2025, with an ultimate completion date of September 23, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $1,738.12 delivery order to AmerisourceBergen Drug Corp on June 25, 2025, for the supply of Prograf 1 mg capsules (100-count units). This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The pharmaceutical product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Prograf 1 mg capsules (100-count units) with a ceiling value of $1,303.59. This firm fixed-price delivery order, awarded on September 23, 2025, with an ultimate completion date of September 24, 2025, represents a direct fulfillment from AmerisourceBergen's existing contract vehicle. The award was made through open competition with no set-aside designation, and performance will take place at the...
- The Defense Logistics Agency awarded a delivery order valued at $41,735.37 to AmerisourceBergen Drug Corp for the supply of Prograf 5 mg capsules (100 count units) under a firm fixed price contract. The award was made on September 17, 2025, with an ultimate completion date of September 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This non-set-aside award represents a competitively awarded transaction for a critical pharmaceutical...
- This is a $39,414.93 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The order is for a quantity of 100 count Prograf 5 mg capsules, which are likely immunosuppressant medications used to prevent organ rejection in transplant patients. The order has a completion date of September 4, 2024. AmerisourceBergen is a major pharmaceutical distributor that provides a wide range of medical products and...
- The Defense Logistics Agency awarded a $18,879.92 delivery order to AmerisourceBergen Drug Corp for Prograf 1 mg capsules (100-count units) on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price contract, which carries no set-aside designation, will be performed at the contractor's facility in Conshohocken, Pennsylvania. Prograf (tacrolimus) is an immunosuppressant medication commonly used in transplant medicine and autoimmune disease management, representing part...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $3,107.15 contract is for the delivery of Prograf 1 mg capsules, a specialty medication, to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Prograf 5 mg capsules (100-count) with a contract ceiling value of $4,252.15. This firm fixed-price delivery order, with an ultimate completion date of September 30, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply needs. The award is non-set-aside and was competitively awarded, reflecting AmerisourceBergen's established...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical for $7,875.20 to supply 100 capsules of the 1 mg Prograf medication. Performance will take place at Amerisourcebergen's headquarters in Conshohocken, Pennsylvania, with all supplies delivered by November 16, 2023. As a prime contractor supporting DLA Troop Support Medical programs, Amerisourcebergen routinely provides pharmaceuticals and medical supplies to...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $11,480.00 firm-fixed price Delivery Order is for the supply of Prograf 1 mg Capsule 100s, a pharmaceutical product. The contract has a period of performance through September 13, 2024. Amerisourcebergen, a major pharmaceutical distributor, is not subject to any set-asides for this award. This award is likely part of...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FYSHRDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,167.21 to AmerisourceBergen Drug Corp for the supply of Prograf 0.5 mg capsules (100 count) under a firm fixed price contract. The order was competitively awarded without set-aside designation and is scheduled for completion by September 30, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor and critical federal vendor, AmerisourceBergen supplies comprehensive pharmaceutical products and medical commodities to support military and veteran healthcare systems. This delivery order for Prograf, an immunosuppressant medication used in transplant patients, aligns with the company's extensive portfolio of brand-name and generic medications supplied through the DLA Medical Supply Chain. The underlying indefinite delivery contract serves as a global pharmaceutical support vehicle enabling AmerisourceBergen to fulfill medical procurement requirements across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 9/29/25 |